NASDAQ:IDXG
Interpace Diagnostics Group Stock News
$1.41
+0 (+0%)
At Close: May 03, 2024
Molecular Diagnostics Market By Key Players, Deployment Type, Applications, Vertical, and Region – Forecast 2026
09:48am, Monday, 11'th May 2020
May 11, 2020 (AmericaNewsHour) --
Global Molecular Diagnostics Market is valued approximately at USD 8.4 billion in 2019 and is anticipated to grow with a...
ARK Genomic Revolution Multi-Sector ETF: An Overbought But Promising Niche Play
02:10pm, Friday, 08'th May 2020
I am neutral on ARKG, an exciting, niche biotech ETF that currently looks overbought on the charts. I expect investor interest in this space to stay elevated on
May 05, 2020 Xherald --
Veterinary Reference Laboratory (VRL) Market report will make detailed analysis mainly on in-depth research on the development...
Viking Therapeutics (VKTX) Received its Third Buy in a Row
11:32am, Saturday, 02'nd May 2020
After Stifel Nicolaus and H.C. Wainwright gave Viking Therapeutics (NASDAQ: VKTX) a Buy rating last month, the company received another
BioCardia (BCDA) Gets a Buy Rating from Maxim Group
04:56pm, Friday, 01'st May 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to BioCardia (BCDA), with a price target of $9.00. The company's shares
BioCardia (BCDA) Gets a Buy Rating from Maxim Group
04:56pm, Friday, 01'st May 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to BioCardia (BCDA – Research Report),
Maxim Group Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
11:47am, Friday, 01'st May 2020
Maxim Group analyst Jason McCarthy maintained a Hold rating on Vertex Pharmaceuticals (VRTX) today. The company's shares closed last Thursday at $251.20.
Maxim Group Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
11:47am, Friday, 01'st May 2020
Maxim Group analyst Jason McCarthy maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today. The company’s shares
H.C. Wainwright Keeps a Buy Rating on CareDx (CDNA)
11:22am, Friday, 01'st May 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on CareDx (CDNA), with a price target of $40.00. The company's shares
H.C. Wainwright Keeps a Buy Rating on CareDx (CDNA)
11:22am, Friday, 01'st May 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on CareDx (CDNA – Research Report),
Analysts' Top Healthcare Picks: Alimera (ALIM), Seattle Genetics (SGEN)
11:22am, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alimera (ALIM) and Seattle Genetics (SGEN) with bullish
Analysts’ Top Healthcare Picks: Alimera (ALIM), Seattle Genetics (SGEN)
11:22am, Friday, 01'st May 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alimera (ALIM
Maxim Group Gives a Hold Rating to Gilead Sciences (GILD)
05:12pm, Thursday, 30'th Apr 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Hold rating to Gilead Sciences (GILD). The company's shares closed last Thursday at
Maxim Group Gives a Hold Rating to Gilead Sciences (GILD)
05:12pm, Thursday, 30'th Apr 2020
In a report released today,
Jason McCarthy
from Maxim Group assigned a
Hold
rating to Gilead Sciences (
GILD
–
Research Report
). The company’s shares closed last Thursday at $81.90, close to its
Immutep (IMMP) Receives a Buy from Maxim Group
02:46pm, Thursday, 30'th Apr 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Immutep (IMMP), with a price target of $2.00. The company's shares
